Nurse-led services are safe and effective in the ambulatory care setting

Added May 10, 2020

Citation: Chan RJ, Marx W, Bradford N, Gordon L, Bonner A, Douglas C, Schmalkuche D, Yates P. Clinical and economic outcomes of nurse-led services in the ambulatory care setting: A systematic review. International journal of nursing studies 2018 May 1;81:61-80.

Free to view: No

What is this? The COVID-19 pandemic is placing a strain on healthcare services. Existing research on nurse-led services may provide useful information for policy makers.

In this systematic review, the authors searched for comparative effectiveness studies of nurse-led services in the ambulatory or community care setting. They restricted their searches to articles published in English up to April 2016. They included 19 randomised trials, 5 pre-post studies and 1 non-randomised controlled trial. The studies were from Asia (3 studies), Australia (4), Europe (15) and USA (3).

What was found: Nurse-led care is a safe and feasible model of care for consideration across various ambulatory care settings.

With appropriate training and support, nurse-led care can lead to similar or better health-related quality of life compared to physician-led care or standard care for patients with chronic conditions.

The economic impact of nurse-led care is uncertain.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.